Other Clinical Trial - ERP to Improve Functioning in Veterans With OCD

Status Recruiting

Clinical Trial Summary

Obsessive compulsive disorder (OCD) is a debilitating psychiatric illness impacting work, social, and family functioning. Exposure and Response Prevention (ERP) is the sole evidence-based psychotherapy for OCD; however, no randomized controlled trials (RCTs) have examined the effectiveness of ERP among Veterans or individuals with both OCD and posttraumatic stress disorder (PTSD). This 4-year Hybrid Type I trial will compare outcomes of ERP to those of a control condition among Veterans with OCD. Primary and secondary aims will examine whether Veterans' functioning, quality of life, and OCD symptoms differ between the ERP and control in the full sample of Veterans with OCD, and in the half of the sample with both OCD and PTSD. The tertiary aim is to conduct a mixed-methods formative evaluation of the implementation potential of ERP in VA mental health settings.

Clinical Trial Description

The proposed 4-year multisite RCT will compare outcomes of VTH-delivered ERP to those of a stress management training control condition among 160 Veterans with OCD. Half of the sample with have comorbid PTSD. The primary aim will examine whether participants' functioning, quality of life, and OCD symptoms differ as a function of the intervention (ERP vs. control). The secondary aim will examine these outcomes among the half of the sample with comorbid OCD and PTSD. The tertiary aim is to conduct a mixed-methods formative evaluation of the implementation potential of ERP in VA mental health settings. Eligible Veteran participants will be randomized to ERP or to the control condition. Veterans randomized to ERP will receive 16 weekly ERP sessions delivered via VTH. Control participants will receive 16 weekly sessions of a stress management training intervention delivered via VTH. Participants in both conditions will complete assessments at post-treatment and 6 months after completing treatment. Participants in the ERP condition will also complete an assessment of treatment satisfaction and a qualitative exit interview assessing the Veterans' perceptions of the impact of treatment on multiple domains of functioning, including the impact on PTSD symptoms. Providers and VA administrators will participate in qualitative interviews regarding the implementation potential of ERP in VA. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05240924
Study type	Interventional
Source	VA Office of Research and Development
Contact	Matthew G Escamilla, BS
Phone	(713) 440-4461
Email	matthew.escamilla@va.gov
Status	Recruiting
Phase	N/A
Start date	October 3, 2022
Completion date	May 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02886780` - "Concentrated Exposure Treatment" (cET) for for Obsessive Compulsive Disorder	N/A
Completed	`NCT00525226` - Evaluating the Effects of Stress in Pregnancy	N/A
Completed	`NCT03476902` - Feasibility, Acceptability, and Preliminary Efficacy of a Mobile App (nOCD) for OCD	N/A
Completed	`NCT01617083` - Antibiotic Treatment Trial for the PANDAS/PANS Phenotype	Phase 2
Completed	`NCT01447966` - Family Based Cognitive-Behavioral Treatment for Preschoolers With Obsessive Compulsive Disorder	N/A
Recruiting	`NCT02528331` - Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study	N/A
Completed	`NCT04432246` - Electroencephalography Predictors of Repetitive Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder	N/A
Not yet recruiting	`NCT02160431` - Neuropsychological Profiles of Pediatric Obsessive Compulsive Disorder (OCD)	N/A
Completed	`NCT02656784` - The Efficacy of TBCT Compared to ERP in the Treatment of OCD Patients, by the Assessment of Magnetic Resonance.	N/A
Recruiting	`NCT01879254` - Long-term Follow-up in Patients With Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD).	N/A
Completed	`NCT00216294` - Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder	Phase 2
Active, not recruiting	`NCT02216981` - Examining the Feasibility and Acceptability of Good Quality Intensive CBT for OCD and Good Quality Weekly CBT for OCD	N/A
Recruiting	`NCT05160129` - Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.